Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas (Q34765380)
Jump to navigation
Jump to search
scientific article published on January 17, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas |
scientific article published on January 17, 2011 |
Statements
1 reference
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas (English)
1 reference
Peter Choyke
1 reference
Jane Trepel
1 reference
Shivaani Kummar
1 reference
Alice Chen
1 reference
Deborah Allen
1 reference
Lamin Juwara
1 reference
Liang Cao
1 reference
Yunkai Yu
1 reference
Yeong Sang Kim
1 reference
Helen Chen
1 reference
Giovanni Melillo
1 reference
Jerry Collins
1 reference
Martin E. Gutierrez
Ismail B. Turkbey
Yvonne R. Horneffer
Jane Trepel
Peter Choyke
Anthony J. Murgo
James H. Doroshow
17 January 2011
1 reference
1 reference
1 reference
47
1 reference
7
1 reference
997-1005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference